New findings presented at the 2024 American Society of Clinical Oncology ASCO annual meeting, a major annual conference where professionals share their latest research in cancer, has revealed that "less" intensive treatment actually results in more progress when it comes to battling ovarian and esophageal cancer, and Hodgkin lymphoma.